Literature DB >> 17562759

Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Antonio Cassone1, Flavia De Bernardis, Giorgio Santoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17562759      PMCID： PMC2044548          DOI： 10.1128/IAI.00083-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  146 in total

Review 1.  Dendritic cell-based vaccination against opportunistic fungi.

Authors:  Silvia Bozza; Claudia Montagnoli; Roberta Gaziano; Giordano Rossi; Gabriel Nkwanyuo; Silvia Bellocchio; Luigina Romani
Journal:  Vaccine       Date:  2004-02-17       Impact factor: 3.641

2.  Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection.

Authors:  Stephen P Saville; Anna L Lazzell; Carlos Monteagudo; Jose L Lopez-Ribot
Journal:  Eukaryot Cell       Date:  2003-10

3.  The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo.

Authors:  Silvia Bellocchio; Claudia Montagnoli; Silvia Bozza; Roberta Gaziano; Giordano Rossi; Salamatu S Mambula; Annunciata Vecchi; Alberto Mantovani; Stuart M Levitz; Luigina Romani
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

4.  An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis.

Authors:  Paul L Fidel; Melissa Barousse; Terri Espinosa; Mercedes Ficarra; Joy Sturtevant; David H Martin; Alison J Quayle; Kathleen Dunlap
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

5.  Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis.

Authors:  Luciano Polonelli; Walter Magliani; Stefania Conti; Luisa Bracci; Luisa Lozzi; Paolo Neri; Daniela Adriani; Flavia De Bernardis; Antonio Cassone
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

6.  Vaginal yeast colonisation, prevalence of vaginitis, and associated local immunity in adolescents.

Authors:  M M Barousse; B J Van Der Pol; D Fortenberry; D Orr; P L Fidel
Journal:  Sex Transm Infect       Date:  2004-02       Impact factor: 3.519

7.  Rat plasmacytoid dendritic cells are an abundant subset of MHC class II+ CD4+CD11b-OX62- and type I IFN-producing cells that exhibit selective expression of Toll-like receptors 7 and 9 and strong responsiveness to CpG.

Authors:  Francois-Xavier Hubert; Cécile Voisine; Cédric Louvet; Michèle Heslan; Régis Josien
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

Review 8.  Toll-like receptors and innate antifungal responses.

Authors:  Alexander Roeder; Carsten J Kirschning; Rudolf A Rupec; Martin Schaller; Hans Christian Korting
Journal:  Trends Microbiol       Date:  2004-01       Impact factor: 17.079

9.  Candida albicans yeast and germ tube forms interfere differently with human monocyte differentiation into dendritic cells: a novel dimorphism-dependent mechanism to escape the host's immune response.

Authors:  Antonella Torosantucci; Giulia Romagnoli; Paola Chiani; Annarita Stringaro; Pasqualina Crateri; Sabrina Mariotti; Raffaela Teloni; Giuseppe Arancia; Antonio Cassone; Roberto Nisini
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

Review 10.  Recombinant antibodies: a natural partner in combinatorial antifungal therapy.

Authors:  Ruth C Matthews; James P Burnie
Journal:  Vaccine       Date:  2004-02-17       Impact factor: 3.641
View more
  18 in total

1.  The effect of antifungal treatment on the vaginal flora of women with vulvo-vaginal yeast infection with or without bacterial vaginosis.

Authors:  G Donders; G Bellen; J Ausma; L Verguts; J Vaneldere; P Hinoul; M Borgers; D Janssens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-28       Impact factor: 3.267

Review 2.  Fungal vaccines and immunotherapeutics.

Authors:  Evelyn Santos; Stuart M Levitz
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

3.  Genetic basis for recurrent vulvo-vaginal candidiasis.

Authors:  Martin Jaeger; Theo S Plantinga; Leo A B Joosten; Bart-Jan Kullberg; Mihai G Netea
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

Review 4.  Host responses to Candida albicans: Th17 cells and mucosal candidiasis.

Authors:  Heather R Conti; Sarah L Gaffen
Journal:  Microbes Infect       Date:  2010-04-08       Impact factor: 2.700

Review 5.  Candida infections of the genitourinary tract.

Authors:  Jacqueline M Achkar; Bettina C Fries
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

6.  Genetically Engineered Virus Nanofibers as an Efficient Vaccine for Preventing Fungal Infection.

Authors:  Yanyan Huai; Shuai Dong; Ye Zhu; Xin Li; Binrui Cao; Xiang Gao; Mingying Yang; Li Wang; Chuanbin Mao
Journal:  Adv Healthc Mater       Date:  2016-02-18       Impact factor: 9.933

Review 7.  Animal models of mucosal Candida infection.

Authors:  Julian R Naglik; Paul L Fidel; Frank C Odds
Journal:  FEMS Microbiol Lett       Date:  2008-04-16       Impact factor: 2.742

Review 8.  Local treatment of vulvovaginal candidosis : general and practical considerations.

Authors:  José das Neves; Eugénia Pinto; Branca Teixeira; Gustavo Dias; Patrocínia Rocha; Teresa Cunha; Bárbara Santos; Maria H Amaral; Maria F Bahia
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  Beneficial effect of Mentha suaveolens essential oil in the treatment of vaginal candidiasis assessed by real-time monitoring of infection.

Authors:  Donatella Pietrella; Letizia Angiolella; Elisabetta Vavala; Anna Rachini; Francesca Mondello; Rino Ragno; Francesco Bistoni; Anna Vecchiarelli
Journal:  BMC Complement Altern Med       Date:  2011-02-28       Impact factor: 3.659

10.  New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges.

Authors:  Anna Vecchiarelli; Eva Pericolini; Elena Gabrielli; Donatella Pietrella
Journal:  Front Microbiol       Date:  2012-08-13       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.